Submit Deal

EYEVANCE PHARMACEUTICALS

HQ - Fort Worth

Summary

Eyevance Pharmaceuticals operates as a pharmaceutical company. The Company focuses on developing and commercializing ophthalmic products that enable optimal vision.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 173 M

Avg. Deal Size£ 173 M

Market Context

Senior Management

Jerry St. Peter
CEO, Director and Co-Founder
Wes Brazell
CFO
Jason Werner
Founder and COO

Sort

16 Sep 2020|United States|Pharmaceuticals

Target: EYEVANCE PHARMACEUTICALS

Bidder: SANTEN PHARMACEUTICAL

7 Service Providers

3 Target | 4 Bidder

13 Dealmakers

4 Target | 9 Bidder

£ 172 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy